Dr J Romain Menorrhagia
Definition Heavy, regular bleeding over several cycles with menstrual blood loss greater than 80mls
In the UK
 Each year causes 1 in 20 women between 30-49yrs to visit their GP Commonest cause of iron deficiency anaemia in women of reproductive age
Interesting Facts Tenfold increase in number of periods women experience (reducing family size, less lactation, early menarche, late menopause) If loss >60mls, neg iron balance can occur Clinicians rely on woman’s assessment of menstrual blood loss, which may be inaccurate in 50% cases
History Full gynaecological history Notoriously inaccurate amount of blood loss Number of pads/tampons used Clots/ flooding Frequency of accidents Menstrual chart can be useful
Examination Weight Any signs of endocrine disturbance Abdominal and pelvic examination Cervical smear if indicated
NICE Referral Guidelines If there is suspicion of underlying cancer They also have persistant intermenstrual or postcoital bleeding Despite 3 months of drug treatment the bleeding is still heavy and interfering with quality of life Wish to explore the possibility of surgical intervention rather than persist with drugs They have severe anaemia failing to respond to drugs
Pathophysiology Menstrual bleeding either ovulatory or anovulatory Regular and painful- ovulatory Irregular and painless- anovulatory With menorrhagia there is evidence of elevated levels of prostaglandins in endometrium and altered responsiveness to vasodilator PGE2.
Pathophysiology Ovulatory bleeding is associated with normal levels of circulating progesterone and oestradiol, therefore altered prostaglandin synthesis is thought to be responsible for increased menstrual loss Ratio of PGE2 and prostacyclin (causing vasodilatation and inhibition of platelet aggregation) and PGF2a (promoting vasoconstriction and platelet aggregation) is significant
Aetiology Physiological- normal loss but interpreted as excessive. Commonly occuring in those who stop the OCP Dysfunctional Uterine Bleeding- diagnosis made after pelvic pathology excluded Congenital- increased endometrial surface area, eg bicornuate uterus Traumatic, eg. IUD
Aetiology Infective, eg. Chronic PID Neoplastic, eg. Fibroids, endometrial polyps Metabolic, eg. Hyperthyroid Psychological factors Adenomyosis Blood dyscrasias Iatrogenic, eg. Warfarin  NOTE- physiological and DUB account for 50%
Investigations Full blood count Thyroid function tests, clotting profiles If suspect infection- endocervical swabs Vaginal Ultrasonography- measure thickness of endometrium (<5mm normal). Detects abnormalities of the cavity eg.polyps. Can assess ovaries and uterus
Investigations Endometrial biopsy should be performed if- menorrhagia is a recent phenomenon woman over 40 yrs if there is any intermenstrual bleeding Even if procedure is performed via D&C it is diagnostic and NOT therapeutic
Treatment If any pathology is found it must be treated, rest aim to treat dysfunctional uterine bleeding Anovulatory- extremes of age. OCP can help. Cyclical progestogens used to induce regular withdrawl bleeds. If these stop, woman has reached menopause Acute arrest for heavy bleeding- high dose reducing course of progestogen
Treatment NSAIDS- inhibit synthesis of prostaglandins, decrease blood loss by up to 30%. Mefanamic acid, given for a few days during menstruation Antifibrinolytic drugs- reduce enhanced fibrinolytic activity within the uterus. Up to 50% reduction. Tranexamic acid Oral Contraceptive Pill- ovulation suppressed and oestrogen levels remain constant.
Treatment Hormone releasing IUD’s- progestogen released causes atrophy of endometrium. Can cause amenorrhoea Danazol- anti gonadotrophin. Induces atrophy of endometrium due to low level of circulating sex steroids. Androgenic side effects not tolerated well- virilizing effects
Treatment Endometrial ablation or resection- visualised hysteroscopically and ablated. Many methods-laser, rollerball, hydrothermal, cryoablation, microwave. Can become amenorrhoeic but not always successful Hysterectomy- definative treatment if family complete.
THANKS!

Menorrhagia

  • 1.
    Dr J RomainMenorrhagia
  • 2.
    Definition Heavy, regularbleeding over several cycles with menstrual blood loss greater than 80mls
  • 3.
    In the UK
Each year causes 1 in 20 women between 30-49yrs to visit their GP Commonest cause of iron deficiency anaemia in women of reproductive age
  • 4.
    Interesting Facts Tenfoldincrease in number of periods women experience (reducing family size, less lactation, early menarche, late menopause) If loss >60mls, neg iron balance can occur Clinicians rely on woman’s assessment of menstrual blood loss, which may be inaccurate in 50% cases
  • 5.
    History Full gynaecologicalhistory Notoriously inaccurate amount of blood loss Number of pads/tampons used Clots/ flooding Frequency of accidents Menstrual chart can be useful
  • 6.
    Examination Weight Anysigns of endocrine disturbance Abdominal and pelvic examination Cervical smear if indicated
  • 7.
    NICE Referral GuidelinesIf there is suspicion of underlying cancer They also have persistant intermenstrual or postcoital bleeding Despite 3 months of drug treatment the bleeding is still heavy and interfering with quality of life Wish to explore the possibility of surgical intervention rather than persist with drugs They have severe anaemia failing to respond to drugs
  • 8.
    Pathophysiology Menstrual bleedingeither ovulatory or anovulatory Regular and painful- ovulatory Irregular and painless- anovulatory With menorrhagia there is evidence of elevated levels of prostaglandins in endometrium and altered responsiveness to vasodilator PGE2.
  • 9.
    Pathophysiology Ovulatory bleedingis associated with normal levels of circulating progesterone and oestradiol, therefore altered prostaglandin synthesis is thought to be responsible for increased menstrual loss Ratio of PGE2 and prostacyclin (causing vasodilatation and inhibition of platelet aggregation) and PGF2a (promoting vasoconstriction and platelet aggregation) is significant
  • 10.
    Aetiology Physiological- normalloss but interpreted as excessive. Commonly occuring in those who stop the OCP Dysfunctional Uterine Bleeding- diagnosis made after pelvic pathology excluded Congenital- increased endometrial surface area, eg bicornuate uterus Traumatic, eg. IUD
  • 11.
    Aetiology Infective, eg.Chronic PID Neoplastic, eg. Fibroids, endometrial polyps Metabolic, eg. Hyperthyroid Psychological factors Adenomyosis Blood dyscrasias Iatrogenic, eg. Warfarin NOTE- physiological and DUB account for 50%
  • 12.
    Investigations Full bloodcount Thyroid function tests, clotting profiles If suspect infection- endocervical swabs Vaginal Ultrasonography- measure thickness of endometrium (<5mm normal). Detects abnormalities of the cavity eg.polyps. Can assess ovaries and uterus
  • 13.
    Investigations Endometrial biopsyshould be performed if- menorrhagia is a recent phenomenon woman over 40 yrs if there is any intermenstrual bleeding Even if procedure is performed via D&C it is diagnostic and NOT therapeutic
  • 14.
    Treatment If anypathology is found it must be treated, rest aim to treat dysfunctional uterine bleeding Anovulatory- extremes of age. OCP can help. Cyclical progestogens used to induce regular withdrawl bleeds. If these stop, woman has reached menopause Acute arrest for heavy bleeding- high dose reducing course of progestogen
  • 15.
    Treatment NSAIDS- inhibitsynthesis of prostaglandins, decrease blood loss by up to 30%. Mefanamic acid, given for a few days during menstruation Antifibrinolytic drugs- reduce enhanced fibrinolytic activity within the uterus. Up to 50% reduction. Tranexamic acid Oral Contraceptive Pill- ovulation suppressed and oestrogen levels remain constant.
  • 16.
    Treatment Hormone releasingIUD’s- progestogen released causes atrophy of endometrium. Can cause amenorrhoea Danazol- anti gonadotrophin. Induces atrophy of endometrium due to low level of circulating sex steroids. Androgenic side effects not tolerated well- virilizing effects
  • 17.
    Treatment Endometrial ablationor resection- visualised hysteroscopically and ablated. Many methods-laser, rollerball, hydrothermal, cryoablation, microwave. Can become amenorrhoeic but not always successful Hysterectomy- definative treatment if family complete.
  • 18.